azd2563 has been researched along with pbtz169 in 1 studies
| Studies (azd2563) | Trials (azd2563) | Recent Studies (post-2010) (azd2563) | Studies (pbtz169) | Trials (pbtz169) | Recent Studies (post-2010) (pbtz169) |
|---|---|---|---|---|---|
| 29 | 0 | 9 | 50 | 0 | 47 |
| Protein | Taxonomy | azd2563 (IC50) | pbtz169 (IC50) |
|---|---|---|---|
| Cytochrome P450 2C19 | Homo sapiens (human) | 3.77 | |
| Decaprenylphosphoryl-beta-D-ribose oxidase | Mycobacterium tuberculosis H37Rv | 0.01 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biava, M; Cocozza, M; Consalvi, S; Poce, G | 1 |
1 review(s) available for azd2563 and pbtz169
| Article | Year |
|---|---|
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
Topics: Animals; Antitubercular Agents; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |